Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Jennifer L. Good is the CEO of Trevi Therapeutics, Inc., a biopharmaceutical company dedicated to developing novel treatments for serious and chronic conditions. Goods leadership is characterized by a focus on advancing clinical development, fostering innovation, and addressing unmet medical needs. With extensive experience in pharmaceutical management and drug development, she has guided Trevi Therapeutics through crucial stages of research and clinical trials. Her commitment to improving patient outcomes and advancing medical science continues to drive the companys mission and position Trevi Therapeutics as a leader in the biopharmaceutical industry.
